Lab Sciences
Top stories summarized by our editors
1/22/2018

A study in the journal Proceedings of the National Academy of Sciences found the incidence of HIV in the Ukraine has risen by 15% to 54%, particularly in areas affected by military conflict. About half of people with HIV are unaware of their status, researcher Tetyana Vasylyeva said.

More Summaries:
HIV
1/22/2018

China aims to become a major player in the field of experimental gene therapy with 153 chimeric antigen receptor T-cell studies ongoing in the country, compared with 186 in the US.

Full Story:
Bloomberg Gadfly
More Summaries:
Center for Drug Evaluation, FDA
1/22/2018

The Senate has reached an agreement to end the government shutdown after Senate Majority Leader Mitch McConnell, R-Ky., promised to open debate on immigration. Senators were set to vote on a short-term spending bill that provides funding through Feb. 8, with the House expected to later approve the measure and send it to the president.

1/19/2018

A robot-aided study in the journal Scientific Reports found that triclosan inhibits not just enoyl reductase but also the enzyme dihydrofolate reductase in malarial parasites. The robot, called Eve, was developed to use artificial intelligence and machine learning to run faster laboratory experiments.

1/19/2018

The Zimbabwe Healthcare Fund will receive $502 million over three years from the Global Fund to Fight AIDS, Tuberculosis and Malaria. Most of the funding will go toward providing HIV prevention, care and support.

Full Story:
Newsday (Zimbabwe)
More Summaries:
HIV
1/19/2018

GC Pharma of South Korea has been granted approval by the country's Ministry of Food and Drug Safety to proceed with a Phase II/III clinical study of its Hepabig-gene recombinant hepatitis B immunoglobulin. The multi-center study will compare Hepabig-gene with current treatments for liver transplant recipients with hepatitis B.

1/19/2018

A Series A funding round brought in $58 million for Pandion Therapeutics. The company is developing bispecific antibodies as potential treatments for autoimmune liver diseases and inflammatory bowel disease.

Full Story:
BioCentury
More Summaries:
bowel disease, Series A
1/18/2018

The Senate Finance Committee voted 15-12 to advance Alex Azar's nomination as HHS secretary. The former Eli Lilly and Co. executive now faces a vote in the full Senate, where confirmation is expected.

1/18/2018

CDC and Brazilian researchers analyzed data on Zika virus infections and microcephaly for births in Brazil's Paraiba state between Aug. 1, 2015, and Feb. 1, 2016, and found that infants with microcephaly were more likely to have had Zika virus infection or been born to a mother who had Zika infection in the first trimester. The findings were published in The Lancet Child & Adolescent Health.

More Summaries:
microcephaly, CDC
1/18/2018

Janssen's Darzalex, or daratumumab, was endorsed by the National Institute for Health and Care Excellence for use in adults who have received previous treatment for multiple myeloma. The treatment will be available through the Cancer Drugs Fund.

Full Story:
PharmaTimes (U.K.)